BNP (B-type Natriuretic Peptide) Dosage Guide

Complete guide to BNP (B-type Natriuretic Peptide) dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Nesiritide (recombinant BNP): 2mcg/kg IV bolus followed by 0.01mcg/kg/min continuous infusion for acute decompensated heart failure.

Administration Method

Intravenous administration only. Used in acute care settings for heart failure. BNP levels also used diagnostically.

Side Effects to Monitor

Hypotension (common and dose-limiting), headache, nausea, and potential renal function worsening in some patients.

Safety Considerations & Risks

Controversial efficacy data. Concerns about renal effects and mortality in some studies led to reduced use. Requires careful hemodynamic monitoring.